Cyfuse Biomedical K.K.
¥607
5
-¥8-1.3% Friday 06:30
Statistics
Day High
610
Day Low
596
52W High
764
52W Low
487
Volume
23,100
Avg. Volume
31,862
Mkt Cap
5.83B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
12NovExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-30
-24
-18
-12
Expected EPS
N/A
Actual EPS
N/A
Financials
-416.59%Profit Margin
Unprofitable104.32MRevenue
-434.59MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap162.16B
Novartis
NVS
Mkt Cap304.1B
Merck
MRK
Mkt Cap370.89B
Medtronic
MDT
Mkt Cap120.46B
Abbott Laboratories
ABT
Mkt Cap187.45B
Roche
RHHBY
Mkt Cap334.28B
Bristol-Myers Squibb
BMY
Mkt Cap136.49B
Johnson & Johnson
JNJ
Mkt Cap663.28B
AMGEN
AMGN
Mkt Cap236.38B
Gilead Sciences
GILD
Mkt Cap187.23B
About
Established in 2010 and headquartered in Tokyo, Japan, Cyfuse Biomedical K.K. focuses on the creation, production, and distribution of regenerative medicine solutions. The company is actively involved in developing cell-based products for therapeutic regeneration, and it also undertakes contract work for cellular product research and development. Furthermore, Cyfuse Biomedical offers advanced Bio 3D Printers, which are instrumental in regenerating a variety of tissues and organs, including cartilage, bones, blood vessels, and nerves. Their specialized equipment includes 'regenova,' a bio 3D printer enabling three-dimensional cell stacking, and 'S-PIKE,' designed for forming complex 3D structures from cells.
Show more...
CEO
Shizuka Akieda
Employees
23
Country
Japan
ISIN
JP3311800001
Listings
0 Comments
Share your thoughts
FAQ
What is Cyfuse Biomedical K.K. stock price today?▼
The current price of 4892.TSE is ¥607 JPY — it has decreased by -1.3% in the past 24 hours. Watch Cyfuse Biomedical K.K. stock price performance more closely on the chart.
What is Cyfuse Biomedical K.K. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Tokyo Stock Exchange exchange Cyfuse Biomedical K.K. stocks are traded under the ticker 4892.TSE.
Is Cyfuse Biomedical K.K. stock price growing?▼
4892.TSE stock has fallen by -0.65% compared to the previous week, the month change is a +8.59% rise, over the last year Cyfuse Biomedical K.K. has showed a +3.94% increase.
What is Cyfuse Biomedical K.K. market cap?▼
Today Cyfuse Biomedical K.K. has the market capitalization of 5.83B
When is the next Cyfuse Biomedical K.K. earnings date?▼
Cyfuse Biomedical K.K. is going to release the next earnings report on November 12, 2026.
What were Cyfuse Biomedical K.K. earnings last quarter?▼
4892.TSE earnings for the last quarter are -20 JPY per share, whereas the estimation was N/A JPY resulting in a N/A surprise. The estimated earnings for the next quarter are N/A JPY per share.
What is Cyfuse Biomedical K.K. revenue for the last year?▼
Cyfuse Biomedical K.K. revenue for the last year amounts to 104.32M JPY.
What is Cyfuse Biomedical K.K. net income for the last year?▼
4892.TSE net income for the last year is -434.59M JPY.
How many employees does Cyfuse Biomedical K.K. have?▼
As of September 12, 2026, the company has 23 employees.
In which sector is Cyfuse Biomedical K.K. located?▼
Cyfuse Biomedical K.K. operates in the Health & Wellness sector.
When did Cyfuse Biomedical K.K. complete a stock split?▼
Cyfuse Biomedical K.K. has not had any recent stock splits.
Where is Cyfuse Biomedical K.K. headquartered?▼
Cyfuse Biomedical K.K. is headquartered in Tokyo, Japan.